The limited effectiveness of approved treatments for Multiple Sclerosis (MS), as well as reports of adverse events and toxicity, emphasize the need for the development of new therapies with improved efficacy and fewer side effects. Recently...
The limited effectiveness of approved treatments for Multiple Sclerosis (MS), as well as reports of adverse events and toxicity, emphasize the need for the development of new therapies with improved efficacy and fewer side effects. Recently...